<?xml version='1.0' encoding='utf-8'?>
<regulation prefix="Regulation" num=".18" citation="COMAR 10.06.01.18" title_num="10" subtitle_num="06" chapter_num="01" heading="Other Sexually Transmitted Infections.">
  <paragraph num="A.">
    <text>Control of a Case.</text>
    <paragraph num="(1)">
      <text>Hepatitis, viral type B, as discussed in Regulation .11 of this chapter.</text>
    </paragraph>
    <paragraph num="(2)">
      <text>A physician in attendance upon a person who appears to have, or who has a sexually transmissible disease in a stage which is or may become communicable, shall:</text>
      <paragraph num="(a)">
        <text>Instruct the person on the modes of transmission and the prevention of transmission;</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Render any necessary treatment to the case; and</text>
      </paragraph>
      <paragraph num="(c)">
        <text>Advise the case to inform a sexual partner or partners of exposure and the need for examination and treatment.</text>
      </paragraph>
    </paragraph>
  </paragraph>
  <paragraph num="B.">
    <text>Control of Contacts.</text>
    <paragraph num="(1)">
      <text>Hepatitis, viral type B as discussed in Regulation .11 of this chapter</text>
    </paragraph>
    <paragraph num="(2)">
      <text>A physician in attendance upon an individual who is a sexual contact of a case of a sexually transmitted infection shall perform a medical examination and render indicated treatment.</text>
    </paragraph>
  </paragraph>
  <paragraph num="C.">
    <text>Prevention of Gonococcal Ophthalmia Neonatorum.</text>
    <paragraph num="(1)">
      <text>A birth-attending physician or certified nurse-midwife shall apply to both eyes of a newborn one of the following prophylactic agents:</text>
      <paragraph num="(a)">
        <text>A 1-percent silver nitrate solution provided in individual wax ampules for the prevention of gonococcal ophthalmia neonatorum;</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Tetracycline ophthalmic ointment; or</text>
      </paragraph>
      <paragraph num="(c)">
        <text>Erythromycin ophthalmic ointment (USP).</text>
      </paragraph>
    </paragraph>
    <paragraph num="(2)">
      <text>A birth-attending physician or certified nurse-midwife shall document in a newborn's medical record the application of the prophylactic agent, the name of the agent used, and dose strength.</text>
    </paragraph>
  </paragraph>
</regulation>